Keywords
How to Cite
Abstract
Ushbu maqola gen terapiyasi va CRISPR texnologiyasining zamonaviy yo’nalishlarini o‘rganishga bag‘ishlangan. Asosiy e’tibor gen terapiyasining klinik qo‘llanilishi, CRISPR/Cas tizimi yordamida gen tahriri, uning imkoniyatlari va cheklovlariga qaratilgan. Tadqiqotda ilg‘or ilmiy manbalar tahlil qilinib, gen terapiyasi va CRISPR texnologiyasining amaliy natijalari va kelajak istiqbollari ko‘rsatildi. Shuningdek, maqolada xavfsizlik, etik masalalar va gen tahririning inson salomatligiga ta’siri ham muhokama qilinadi.
References
1. Smith J. et al., Advances in Gene Therapy — London: Academic Press, 2020. – 112-b.
2. Johnson L. et al., Lentiviral Vectors in Hematology — New York: Springer, 2021. – 87-b.
3. Lee K. et al., CAR-T Cell Therapy in Oncology — Boston: Elsevier, 2022. – 134-b.
4. Doudna J., Charpentier E., The CRISPR Revolution — New York: W.W. Norton, 2015. – 55-b.
5. Wang Y. et al., CRISPR-Cas9 in Hematologic Disorders — London: Nature Publishing, 2021. – 78-b.
6. Kim H. et al., In vivo CRISPR Applications — Berlin: Springer, 2022. – 101-b.
7. Brown T. et al., Gene Editing for Inherited Blindness — Oxford: Oxford University Press, 2020. – 65-b.
8. Carroll D., Genome Editing: Methods and Protocols — Totowa: Humana Press, 2016. – 92-b.
9. Barrangou R., CRISPR-Cas Systems: Biology and Applications — Amsterdam: Elsevier, 2017. – 110-b.
This work is licensed under a Creative Commons Attribution 4.0 International License.